about
Application and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine TumorsTowards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.Postradiation changes in tissues: evaluation by imaging studies with emphasis on fluorodeoxyglucose-PET/computed tomography and correlation with histopathologic findings.MR Imaging-Guided Attenuation Correction of PET Data in PET/MR Imaging.MR Imaging-Guided Partial Volume Correction of PET Data in PET/MR Imaging.PET and MR Imaging of Brain Tumors.Structure-Function-Based Quantitative Brain Image Analysis.Competing Technology for PET/Computed Tomography: Diffusion-weighted Magnetic Resonance Imaging.Clinical PET/MR Imaging in Dementia and Neuro-Oncology.FDG PET in the Evaluation of Parkinson's Disease.Prognostic Utility of PET in Prostate Cancer.PET Imaging of Prostate Cancer Using C-Acetate.Radiotherapy planning.PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy).Investigation of Nonneoplastic Neurologic Disorders with PET and MRI.Prediction and Early Detection of Response by NMR Spectroscopy and ImagingAttenuation Correction for Magnetic Resonance Coils in Combined PET/MR Imaging: A Review.Diffuse Optical Technology: A Portable and Simple Method for Noninvasive Tissue Pathophysiology.Copper-64 Radiopharmaceuticals for Oncologic ImagingFDG PET in Prostate Cancer.PET Imaging of Angiogenesis.Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors.PET Radiotracers for Imaging the Proliferative Status of Solid Tumors.PET imaging for Treatment Response in CancerDisease Restaging and Diagnosis of Recurrent and Metastatic Disease Following Primary Therapy with FDG-PET Imaging.Positron Emission Tomography Imaging of Hypoxia.Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging.PET in Cerebrovascular Disease.Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.68Ga-DOTA-peptides in the diagnosis of NET.Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.Other PET tracers for neuroendocrine tumors.Preclinical studies of SPECT and PET tracers for NET.Yttrium-based therapy for neuroendocrine tumors.Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy.
P1433
Q26783272-3916F7EF-E8F3-48EE-8816-70DBFD57A9DEQ30435832-6878FC7E-3943-49AF-AEA8-B79DC77A9296Q30836798-5D06BC04-83AF-4298-8244-3C778AF8F63BQ31054295-FD76CC68-CC28-47EE-A3BD-1B988D5361B3Q31054301-3081D603-D814-453C-8443-D28FF426F80EQ31093010-7A5BF3A3-CC1B-4EC9-95B6-D1BA43EACB42Q31093406-12876350-667D-4620-AA60-08C9EDEB8E52Q31093561-62698E14-2239-434D-84E3-8F5C512C8211Q31126677-E930101A-DEAD-4CE7-93EC-21886FBFE64DQ34035765-BBC2C713-5526-4860-B766-20E4DC9AE38CQ35244433-290429FB-6825-4CF8-844C-0F13B898B109Q35288176-55881067-7349-4A0F-8136-AB164514E875Q35591534-0445F78F-98D6-4075-800C-50F977CDCCBBQ35776939-6A9E3F97-CE88-4B5A-B26F-233EF6F536C2Q35780705-78AFC7EF-21B8-4E71-8161-4292BFC4AAF1Q36011651-C6D6344A-B608-4779-AD79-0B5825A0F01CQ36050407-3C7E92A2-ACCA-4D9C-9D5F-C92F14E50E5BQ36672140-EEB9748D-9B2B-450F-BDF2-E4DBC7BA456AQ36821185-F01FE957-A595-4057-A651-8E05C6900E95Q37126530-EF69B0DB-A3CC-4B19-BDDB-797180D3B973Q37352995-91675FFA-DADB-4D6A-9A6B-1DAD60BAA3EAQ37366243-C05CDC68-5079-4DA3-9E00-3CBFDF72D012Q37386875-19BEB53B-F017-4346-8850-0C9BF1076BB8Q37401153-BE7F3CBE-D426-4A39-BA30-DB73110E678DQ37465205-C75F1DC1-E1AF-4E91-88E8-35E339BF1C39Q37477631-48C87911-7DFC-4DF4-A7F4-3898AD8DA48DQ37666742-2B611C97-3190-4D9B-B1AD-E6B233EAE94EQ37706110-CCC5B363-397E-4014-B4C6-E64FBBF1D541Q37720604-4653A178-5972-4A7B-BE27-2B3C63983CD7Q37764708-388060BF-B33F-494E-B171-584665565306Q38230176-94AAB990-6BD8-4476-964F-A0A70DB79613Q38230178-4D29D600-37CB-4233-A819-BA8E976AE4D7Q38230179-DECAF885-E4CE-464D-8CD5-41B3ABBAC347Q38230180-1F505DEC-264E-478C-A27C-2AFF0207CBFFQ38230181-77BEB055-B658-48F0-9B41-667FBA70AB93Q38230182-18F1CADD-015C-4756-90E7-DF05A2F06231Q38230183-156CB263-796D-40AD-BBDB-6B57EFC2F690Q38230184-B3BDFF2A-FB87-43AC-936B-0ECFA71B93E0Q38230186-50104C7A-66CE-4C28-BC3A-30E1A254BB84Q38230187-E3A90806-F211-4C2F-A5CC-60EF0B4D419D
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
PET clinics
@ast
PET clinics
@en
PET clinics
@es
PET clinics
@it
PET clinics
@nl
type
label
PET clinics
@ast
PET clinics
@en
PET clinics
@es
PET clinics
@it
PET clinics
@nl
prefLabel
PET clinics
@ast
PET clinics
@en
PET clinics
@es
PET clinics
@it
PET clinics
@nl
P3181
P1055
P1156
17500155129